Literature DB >> 25449925

Biodegradable chitosan microparticles induce delayed STAT-1 activation and lead to distinct cytokine responses in differentially polarized human macrophages in vitro.

David Fong1, Marianne B Ariganello2, Joël Girard-Lauzière1, Caroline D Hoemann3.   

Abstract

Current data suggest that chitosan activates wound macrophages to release endogenous factors that guide mesenchymal stem cell (MSC) to bone fractures. We tested the hypothesis that chitosan, a polymer containing glucosamine and N-acetyl glucosamine, stimulates macrophages in different polarization states to release functional MSC chemokines and mainly anabolic factors. Low-serum conditioned medium was collected from M0, M1 and M2a U937 macrophages previously differentiated with phorbol myristate acetate (PMA) and exposed or not for 24h to chitosan microparticles (80% degree of deacetylation, DDA, 130kDa). Chitosan particles were highly phagocytosed. Chitosan enhanced anabolic factor release from M0 and M2a macrophages (MCP-1, IP-10, MIP-1beta, IL-1ra, IL-10, PDGF), and IL-1beta release, with 25- to 400-fold excess IL-1ra over IL-1beta. In M1 macrophages, chitosan enhanced IL-1beta without enhancing or suppressing inflammatory factor release (IL-6, IP-10, IL-8). M0 and M2a macrophages, with or without chitosan stimulation, produced conditioned medium that promoted 2-fold more MSC chemotaxis than low-serum control medium, while M1-conditioned medium failed to induce MSC chemotaxis. Acetylated chitosan induced U937 macrophages to release IL-1ra without STAT-6 activation, and also induced a delayed STAT-1 activation/IP-10 release response that was not observed using non-biodegradable chitosan (98% DDA, 130kDa). In primary human macrophages, acetylated chitosan enhanced IL-1ra release without inducing IL-1beta, and required PMA priming to elicit STAT-1 activation and IP-10 release. We conclude that biodegradable chitosan particles enhance M0 and M2a macrophage anabolic responses independent of the IL4/STAT-6 axis, by inducing excess IL-1ra over IL-1beta and more chemokine release, without altering their inherent capacity to attract MSCs.
Copyright © 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chitin/chitosan; Immunomodulation; Inflammation; Macrophage; Mesenchymal stem cells

Mesh:

Substances:

Year:  2014        PMID: 25449925     DOI: 10.1016/j.actbio.2014.10.026

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  5 in total

1.  Newly synthesized chitosan-nanoparticles attenuate carbendazim hepatorenal toxicity in rats via activation of Nrf2/HO1 signalling pathway.

Authors:  Elshazly Mo; Yasmin A Ebedy; Marwa A Ibrahim; Khaled Y Farroh; Eman I Hassanen
Journal:  Sci Rep       Date:  2022-06-15       Impact factor: 4.996

2.  Chitosan immunomodulatory properties: perspectives on the impact of structural properties and dosage.

Authors:  David Fong; Caroline D Hoemann
Journal:  Future Sci OA       Date:  2017-09-14

3.  Surface nanocavitation of titanium modulates macrophage activity.

Authors:  Marianne B Ariganello; Dainelys Guadarrama Bello; Alejandra Rodriguez-Contreras; Shayan Sadeghi; Gaetano Isola; Fabio Variola; Antonio Nanci
Journal:  Int J Nanomedicine       Date:  2018-12-05

4.  Enhancing Macrophage Drug Delivery Efficiency via Co-Localization of Cells and Drug-Loaded Microcarriers in 3D Resonant Ultrasound Field.

Authors:  Yu-Hsiang Lee; Zhen-Yu Wu
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

5.  Biodegradable Chitosan Decreases the Immune Response to Trichinella spiralis in Mice.

Authors:  Klaudia Brodaczewska; Natalia Wolaniuk; Katarzyna Lewandowska; Katarzyna Donskow-Łysoniewska; Maria Doligalska
Journal:  Molecules       Date:  2017-11-18       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.